www.fool.com Open in urlscan Pro
172.64.147.90  Public Scan

Submitted URL: https://email.analystratings.net/ls/click?upn=u001.WeKo-2BCuHku2kJmVIsYmGxuYr2srlLtYnnWDpKGijlvvbzplfpd-2FFtizxHxvIQR-2BDaDu8mg2F...
Effective URL: https://www.fool.com/investing/2024/12/27/prediction-this-will-be-amazons-next-big-buyout/
Submission: On December 27 via api from BE — Scanned from CA

Form analysis 4 forms found in the DOM

POST javascript:void(0)

<form action="javascript:void(0)" data-ftm-derby="9891" data-ftm-heat="15422" data-ftm-pit="16739" data-ftm-veh="in_line_article_pitch" data-impression-id="1d567301-0863-4faa-bd22-ae09c2fde0a9" id="ecapWidgetForm" method="POST"><input id="aid"
    name="aid" type="hidden" value="11010"> <input id="src" name="src" type="hidden" value="isaediica0000008"><label style="display: inline-block;"><span class="email-text sr-only">Enter Email Address:</span><input 0="" class="email"
      data-no-resize="true" id="email-input" margin-right:="" name="email" placeholder="Enter Email" type="email" data-uw-rm-form="nfx"></label> <input aria-label="Get Started Now" class="foolcom-btn-cyan foolcom-btn" name="button" type="submit"
    value="Sign Up" data-uw-rm-form="nfx"><input id="pitchClickUrl" name="pitchClickUrl" type="hidden"
    value="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=1d567301-0863-4faa-bd22-ae09c2fde0a9&amp;url=https%3A%2F%2Fwww.fool.com%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Din_line_article_pitch%26ftm_pit%3D16739%26aid%3D11010%26source%3Disaediica0000008"><input
    id="ftm_pit" name="ftm_pit" type="hidden" value="16739"><input id="ftm_cam" name="ftm_cam" type="hidden" value="sa-breakfast-news"><input id="ftm_veh" name="ftm_veh" type="hidden" value="in_line_article_pitch"><input id="prevent-ecap-redirect"
    name="prevent-ecap-redirect" type="hidden" value="True"><input id="InfoTrackClickImpression" name="InfoTrackClickImpression" type="hidden" value="1d567301-0863-4faa-bd22-ae09c2fde0a9"></form>

<form class="sm:flex max-w-740 mb-12px" id="ecap-form" onsubmit="handleEcapFormSubmit(event)">
  <div class="font-bold" id="ecap-submit-message"></div>
  <div class="mt-20px">
    <div class="text-sm">By submitting your email address,&nbsp;you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. Please read our
      <a aria-label="Privacy Statement - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=1d567301-0863-4faa-bd22-ae09c2fde0a9&amp;url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fprivacy-statement%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Din_line_article_pitch%26ftm_pit%3D16739%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/privacy-statement/$privacystatement">Privacy Statement</a>
      and
      <a aria-label="Terms &amp; Conditions - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=1d567301-0863-4faa-bd22-ae09c2fde0a9&amp;url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fterms-and-conditions%2Ffool-rules%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Din_line_article_pitch%26ftm_pit%3D16739%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/terms-and-conditions/fool-rules/$terms&amp;conditions">Terms &amp; Conditions</a>.
    </div>
    <input id="prevent-ecap-redirect" name="prevent-ecap-redirect" type="hidden" value="True">
  </div>
</form>

POST javascript:void(0)

<form action="javascript:void(0)" data-ftm-derby="9893" data-ftm-heat="15420" data-ftm-pit="16660" data-ftm-veh="foolcom_sidebar_service" data-impression-id="174d68ff-f178-44a8-aa2b-e5c959660415" id="ecapWidgetForm" method="POST"><input id="aid"
    name="aid" type="hidden" value="11010"> <input id="src" name="src" type="hidden" value="isaedisdb0000010"><label style="display: inline-block;"><span class="email-text sr-only">Enter Email Address:</span><input 0="" class="email"
      data-no-resize="true" id="email-input" margin-right:="" name="email" placeholder="Enter Email" type="email" data-uw-rm-form="nfx"></label> <input aria-label="Get Started Now" class="foolcom-btn-cyan foolcom-btn" name="button" type="submit"
    value="Sign Up" data-uw-rm-form="nfx"><input id="pitchClickUrl" name="pitchClickUrl" type="hidden"
    value="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=174d68ff-f178-44a8-aa2b-e5c959660415&amp;url=https%3A%2F%2Fwww.fool.com%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Dfoolcom_sidebar_service%26ftm_pit%3D16660%26aid%3D11010%26source%3Disaedisdb0000010"><input
    id="ftm_pit" name="ftm_pit" type="hidden" value="16660"><input id="ftm_cam" name="ftm_cam" type="hidden" value="sa-breakfast-news"><input id="ftm_veh" name="ftm_veh" type="hidden" value="foolcom_sidebar_service"><input id="prevent-ecap-redirect"
    name="prevent-ecap-redirect" type="hidden" value="True"><input id="InfoTrackClickImpression" name="InfoTrackClickImpression" type="hidden" value="174d68ff-f178-44a8-aa2b-e5c959660415"></form>

<form class="sm:flex max-w-740 mb-12px" id="ecap-form" onsubmit="handleEcapFormSubmit(event)">
  <div class="font-bold" id="ecap-submit-message"></div>
  <div class="mt-20px">
    <div class="text-sm">By submitting your email address,&nbsp;you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. Please read our
      <a aria-label="Privacy Statement - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=174d68ff-f178-44a8-aa2b-e5c959660415&amp;url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fprivacy-statement%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Dfoolcom_sidebar_service%26ftm_pit%3D16660%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/privacy-statement/$privacystatement">Privacy Statement</a>
      and
      <a aria-label="Terms &amp; Conditions - open in a new tab" data-uw-rm-ext-link="" href="https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&amp;impression=174d68ff-f178-44a8-aa2b-e5c959660415&amp;url=https%3A%2F%2Fwww.fool.com%2Flegal%2Fterms-and-conditions%2Ffool-rules%2F%3Fftm_cam%3Dsa-breakfast-news%26ftm_veh%3Dfoolcom_sidebar_service%26ftm_pit%3D16660%26source%3D%26aid%3D" rel="nofollow" target="_blank" uw-rm-external-link-id="https://www.fool.com/legal/terms-and-conditions/fool-rules/$terms&amp;conditions">Terms &amp; Conditions</a>
    </div>
    <input id="prevent-ecap-redirect" name="prevent-ecap-redirect" type="hidden" value="True">
  </div>
</form>

Text Content

Skip to main contentEnable accessibility for low visionOpen the accessibility
menu








Search
▲ S&P 500 +176% | ▲ Stock Advisor +922% Join The Motley Fool
Accessibility Log In Help
Accessibility Menu
Our Services
Stock Market News angle-down
Stock News
 * Stock Market News
 * Market Movers
 * Tech Stock News
 * Market Trends
 * Consumer Stock News
 * Crypto News
 * Industrial Stock News

Markets
 * Stock Market Indexes Today
 * Most Active Stocks Today
 * Today's Biggest Stock Gainers
 * Today's Biggest Stock Losers
 * Largest Market Cap Companies
 * Market Research
 * 📨 Breakfast News

Best Buys
 * Top Stocks to Buy Now
 * Best ETFs to Buy
 * Best AI Stocks
 * Best Growth Stocks
 * Dividend Kings
 * Best Index Funds
 * Next Cryptos to Explode

Industries to Invest In
 * Technology
 * Energy
 * Real Estate
 * Healthcare
 * Consumer Goods
 * Materials
 * Industrials

How to Invest angle-down
Investing 101
 * How to Invest Money
 * What to Invest In
 * How to Invest in Stocks
 * How to Invest in ETFs
 * How to Invest in Index Funds
 * How to Invest in Bonds
 * Financial Dictionary

Stock Market Basics
 * Stock Market 101
 * Types of Stocks
 * Stock Market Sectors
 * Stock Market Indexes
 * What Are Stock Splits?
 * What Is Compound Interest?
 * After Hours Trading

Start Investing
 * How to Buy Stock
 * Best Brokers for Beginners
 * Best Brokerage Accounts
 * Good Time to Buy Stocks
 * How Many Shares to Buy?
 * Portfolio Diversification
 * Long Term Investing Strategies

Companies to Invest In
 * Magnificent Seven Companies
 * Warren Buffett Investments
 * Investing in ChatGPT
 * Investing in SpaceX
 * Investing in OpenAI
 * Investing in Nvidia
 * Investing in Databricks

Retirement angle-down
Retirement Essentials
 * Retirement 101
 * Types of Retirement Accounts
 * How to Contribute to 401k/IRA?
 * Strategies to Save for Retirement
 * Asset Allocation for My Age
 * Best IRA Brokerage Accounts
 * Withdrawal Rules for 401(k) Plans

Social Security Benefits
 * Social Security 101
 * When to Start Social Security?
 * Full Retirement Age
 * COLAs
 * Calculate Your SS Benefits
 * Collecting Spousal Benefits
 * Maximize Social Security Benefit

Planning for Retirement
 * How Much Do I Need to Retire?
 * When To Retire
 * 401(k) Plans
 * 403(b) Plans
 * Roth IRA Plans
 * IRA Plans
 * HSA Plans

Retired: What Now?
 * Complete Retirement Guide
 * Best & Worst States to Retire
 * Average Retirement Savings
 * Moving for Retirement
 * Healthcare in Retirement
 * Understanding Taxes in Retirement
 * 401(k) Minimum Distributions

Personal Finance angle-down
Credit Cards
 * Best Credit Cards
 * Compare Credit Cards
 * Credit Card Reviews
 * Credit Card Guides and Tools

Bank & Loans
 * Best Savings Accounts
 * Bank Reviews
 * Best Personal Loans
 * Personal Loan Reviews

Homebuying
 * Best Mortgage Lenders
 * Current Mortgage Rates
 * Mortgage Lender Reviews
 * Guide to Mortgages

Insurance
 * Auto Insurance
 * Home Insurance
 * Life Insurance
 * Pet Insurance

About Us angle-down
Our Purpose:
To make the world smarter, happier, and richer.

Founded in 1993, The Motley Fool is a financial services company dedicated to
making the world smarter, happier, and richer. The Motley Fool reaches millions
of people every month through our premium investing solutions, free guidance and
market analysis on Fool.com, personal finance education, top-rated podcasts, and
non-profit The Motley Fool Foundation.

Who Is the Motley Fool?
 * About Us
 * Contact Us
 * Investing Philosophy
 * Motley Fool Money
 * The Motley Fool Foundation
 * Reviews
 * Publishing Standards

Fool Podcasts
 * Podcasts Home
 * Motley Fool Money
 * Rule Breaker Investing

Social Media
 * Facebook
 * Twitter
 * YouTube
 * Discussion Boards
 * CAPS - Stock Picking Community

Other Services
 * Newsroom
 * Become an Affiliate Partner

Top 10 Stocks to Buy Now
Bars Times


Search
 * Our Services
 * Stock Market News
   angle-down angle-up
   Stock News
    * Stock Market News
    * Market Movers
    * Tech Stock News
    * Market Trends
    * Consumer Stock News
    * Crypto News
    * Industrial Stock News
   
   Markets
    * Stock Market Indexes Today
    * Most Active Stocks Today
    * Today's Biggest Stock Gainers
    * Today's Biggest Stock Losers
    * Largest Market Cap Companies
    * Market Research
    * 📨 Breakfast News
   
   Best Buys
    * Top Stocks to Buy Now
    * Best ETFs to Buy
    * Best AI Stocks
    * Best Growth Stocks
    * Dividend Kings
    * Best Index Funds
    * Next Cryptos to Explode
   
   Industries to Invest In
    * Technology
    * Energy
    * Real Estate
    * Healthcare
    * Consumer Goods
    * Materials
    * Industrials
 * How to Invest
   angle-down angle-up
   Investing 101
    * How to Invest Money
    * What to Invest In
    * How to Invest in Stocks
    * How to Invest in ETFs
    * How to Invest in Index Funds
    * How to Invest in Bonds
    * Financial Dictionary
   
   Stock Market Basics
    * Stock Market 101
    * Types of Stocks
    * Stock Market Sectors
    * Stock Market Indexes
    * What Are Stock Splits?
    * What Is Compound Interest?
    * After Hours Trading
   
   Start Investing
    * How to Buy Stock
    * Best Brokers for Beginners
    * Best Brokerage Accounts
    * Good Time to Buy Stocks
    * How Many Shares to Buy?
    * Portfolio Diversification
    * Long Term Investing Strategies
   
   Companies to Invest In
    * Magnificent Seven Companies
    * Warren Buffett Investments
    * Investing in ChatGPT
    * Investing in SpaceX
    * Investing in OpenAI
    * Investing in Nvidia
    * Investing in Databricks
 * Retirement
   angle-down angle-up
   Retirement Essentials
    * Retirement 101
    * Types of Retirement Accounts
    * How to Contribute to 401k/IRA?
    * Strategies to Save for Retirement
    * Asset Allocation for My Age
    * Best IRA Brokerage Accounts
    * Withdrawal Rules for 401(k) Plans
   
   Social Security Benefits
    * Social Security 101
    * When to Start Social Security?
    * Full Retirement Age
    * COLAs
    * Calculate Your SS Benefits
    * Collecting Spousal Benefits
    * Maximize Social Security Benefit
   
   Planning for Retirement
    * How Much Do I Need to Retire?
    * When To Retire
    * 401(k) Plans
    * 403(b) Plans
    * Roth IRA Plans
    * IRA Plans
    * HSA Plans
   
   Retired: What Now?
    * Complete Retirement Guide
    * Best & Worst States to Retire
    * Average Retirement Savings
    * Moving for Retirement
    * Healthcare in Retirement
    * Understanding Taxes in Retirement
    * 401(k) Minimum Distributions
 * Personal Finance
   angle-down angle-up
   Credit Cards
    * Best Credit Cards
    * Compare Credit Cards
    * Credit Card Reviews
    * Credit Card Guides and Tools
   
   Bank & Loans
    * Best Savings Accounts
    * Bank Reviews
    * Best Personal Loans
    * Personal Loan Reviews
   
   Homebuying
    * Best Mortgage Lenders
    * Current Mortgage Rates
    * Mortgage Lender Reviews
    * Guide to Mortgages
   
   Insurance
    * Auto Insurance
    * Home Insurance
    * Life Insurance
    * Pet Insurance
 * About Us
   angle-down angle-up
   Who Is the Motley Fool?
    * About Us
    * Contact Us
    * Investing Philosophy
    * Motley Fool Money
    * The Motley Fool Foundation
    * Reviews
    * Publishing Standards
   
   Fool Podcasts
    * Podcasts Home
    * Motley Fool Money
    * Rule Breaker Investing
   
   Social Media
    * Facebook
    * Twitter
    * YouTube
    * Discussion Boards
    * CAPS - Stock Picking Community
   
   Other Services
    * Newsroom
    * Become an Affiliate Partner
   
   Our Purpose:
   To make the world smarter, happier, and richer.
   
   Founded in 1993, The Motley Fool is a financial services company dedicated to
   making the world smarter, happier, and richer. The Motley Fool reaches
   millions of people every month through our premium investing solutions, free
   guidance and market analysis on Fool.com, personal finance education,
   top-rated podcasts, and non-profit The Motley Fool Foundation.
 * Log In
 * Help
 * Join The Motley Fool

Top 10 Stocks to Buy Now
Free Article
You’re reading a free article with opinions that may differ from The Motley
Fool’s Premium Investing Services. Become a Motley Fool member today to get
instant access to our top analyst recommendations, in-depth research, investing
resources, and more. Learn More


PREDICTION: THIS WILL BE AMAZON'S NEXT BIG ACQUISITION

By Adam Spatacco – Dec 27, 2024 at 5:07AM

Key Points

 * Amazon has made several large-scale acquisitions throughout its history.
 * In recent years, two of Amazon's quieter acquisitions came from the
   healthcare space.
 * I see one emerging telemedicine company as the perfect match to bolster
   Amazon's healthcare platform.
 * Buy Alert: Our 10 best stocks to buy right now (see the list)

STOCKS MENTIONED

AMZN
Amazon
$221.71
Arrow-Thin-Down
(-2.4%)
-$5.34
HIMS
Hims & Hers Health
$26.99
Arrow-Thin-Down
(-5.3%)
-$1.50
+1 more Show all


NASDAQ: AMZN


AMAZON



Market Cap
$2,387B

Today's Change
Arrow-Thin-Down
(-2.35%) -$5.34
Current Price
$221.71
Price as of December 27, 2024, 11:50 a.m. ET


Amazon may be known for its retail and tech chops, but the company has also
built a strong operation in the healthcare realm over the last several years.

Amazon (AMZN -2.35%) is primarily known for its e-commerce marketplace and cloud
computing infrastructure business. But believe it or not, Amazon also operates
within several other end markets including streaming, entertainment,
advertising, and more.

One way that Amazon has been able to diversify its business over the years is
through a series of acquisitions. While the majority of Amazon's buyouts have
revolved around the technology sector, the company has made some quiet moves in
the healthcare space in recent years.

In 2018, Amazon acquired online pharmacy business PillPack for $753 million.
Moreover, the company acquired membership-based primary healthcare provider
1Life Healthcare for $3.9 billion in 2023.

These two companies have helped Amazon spearhead its healthcare services,
primarily through Amazon Pharmacy. Below, I'm going to break down which company
I think Amazon could acquire next and explain why I think the deal makes a lot
of sense right now.

Arrows-In Collapse



NASDAQ: AMZN

Amazon
Today's Change
(-2.35%) -US$5.34
Current Price
US$221.71
Arrow-Thin-Down
YTD1w1m3m6m 1y
+49.43%
5y
Price VS S&P
AMZN


KEY DATA POINTS

Market Cap
$2,387B
Day's Range
US$220.90 - US$226.03
52wk Range
US$144.05 - US$233.00
Volume
10,365,015
Avg Vol
38,065,062
Gross Margin
48.41%
Dividend Yield
N/A


AMAZON SHOULD ACQUIRE HIMS & HERS HEALTH

Hims & Hers Health (HIMS -5.26%) is a telemedicine company that specializes in
providing a number of lifestyle and wellness products, including treatments for
skincare, hair growth, weight loss, anxiety, sexual health, and more.



Back in November, Amazon Pharmacy announced that it was expanding its product
offerings to include "common health, beauty, and lifestyle concerns" such as
anti-aging skincare, hair regrowth, and erectile dysfunction.

Right off the bat, I see a lot of overlap between the Hims & Hers platform and
Amazon's bolstered offerings through its online pharmacy. Below, I'll dig into
what makes Hims & Hers a particularly attractive asset for Amazon's ecosystem.


ARE YOU MISSING THE MORNING SCOOP?

Start your day ahead of the game with the market’s top stories and key investing
insights. Breakfast News delivers it all in a quick, Foolish, and free daily
newsletter that lands in your inbox every market morning..
Enter Email Address:
By submitting your email address, you consent to us keeping you informed about
updates to our website and about other products and services that we think might
interest you. Please read our Privacy Statement and Terms & Conditions.

Image source: Getty Images.


WHY HIMS & HERS HEALTH AND AMAZON COULD BE A MATCH MADE IN HEAVEN

Per the chart below, investors can see that the overwhelming majority of revenue
for Hims & Hers Health comes from online. And according to the company's 10Q
filing, "the majority of our online revenue is subscription-based, where
customers agree to be billed on a recurring basis to have products and services
automatically delivered to them."

Image source: Hims & Hers investor relations.

The reason I see Hims & Hers Health as such an attractive asset for Amazon comes
down to one thing: Amazon Prime, the subscription service that offers members a
host of benefits such as free shipping and access to certain entertainment
content through the company's streaming platform.



As I referenced above, two of Amazon's major healthcare-related acquisitions in
recent years include PillPack and 1Life Healthcare. 1Life Healthcare is an
exclusive perk for Prime members, while PillPack and Amazon Pharmacy as a whole
are tailored more toward Prime subscribers (although you technically do not need
to be a Prime member to access some of Amazon Pharmacy's offerings).

I think the obvious synergy opportunity here is for Amazon to roll up Hims &
Hers Health's subscriber base into the Prime membership platform -- thereby
bolstering its online pharmacy capabilities even further and adding a steady
stream of high-margin, recurring revenue in the process.

Arrows-In Collapse



NYSE: HIMS

Hims & Hers Health
Today's Change
(-5.26%) -US$1.50
Current Price
US$26.99
Arrow-Thin-Down
YTD1w1m3m6m 1y
+220.11%
5y
Price VS S&P
HIMS


KEY DATA POINTS

Market Cap
$6B
Day's Range
US$26.70 - US$28.71
52wk Range
US$8.09 - US$35.02
Volume
4,163,711
Avg Vol
17,007,547
Gross Margin
70.63%
Dividend Yield
N/A


NOW LOOKS LIKE THE OPPORTUNITY TO GET A DEAL DONE

Hims & Hers Health is an interesting case study. Although shares have soared by
216% this year, the stock is actually down by nearly 13% just in December.



HIMS data by YCharts



One of the bigger trends influencing recent price action for Hims & Hers Health
stems from the weight loss market. Right now, glucagon-like peptide-1 (GLP-1)
agonists such as Ozempic, Wegovy, Mounjaro, and Zepbound are used to treat
diabetes and chronic weight management. All four of these blockbuster drugs are
made by either Novo Nordisk or Eli Lilly.

While competition in the GLP-1 landscape is sparse, Hims & Hers has been able to
find its own unique pocket by offering patients compounded versions of
treatments such as Ozempic. Compounded medications are not approved by the Food
and Drug Administration (FDA), yet some patients will opt for these knockoffs
purely due to their low cost and ease of access.

For months now, Novo and Lilly have made public comments about compounded GLP-1
treatments and have been making moves of their own to try to make their weight
loss medications more affordable and easier to access.

Furthermore, just this week the FDA removed tirzepatide -- the main ingredient
in Mounjaro and Zepbound -- from its shortage list. This means that compounding
facilities have a limited time (60 to 90 days depending on certain regulatory
frameworks) to continue selling compounded GLP-1s. Once this stops, Hims & Hers
will likely have a much tougher time penetrating the weight loss market, and its
growth could slow down materially.



To me, these developments are directly contributing to the current sell-off in
Hims & Hers Health stock. With a market capitalization of $6.2 billion, Amazon
could easily acquire Hims & Hers Health with cash from the balance sheet.

Given the overlap of product offerings between Amazon Pharmacy and Hims & Hers
Health, combined with the robust recurring revenue base that Amazon could roll
into its Prime membership perks, I see a deal between the two parties as a match
made in heaven.


WHERE SHOULD YOU INVEST $1,000 RIGHT NOW?

Before you put a single dollar into the stock market, consider this:

The Motley Fool Stock Advisor Canada analyst team has identified what they
believe are the 15 best stocks for investors to buy now. The 15 stocks that made
the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you
invested $1,000 in the “eBay of Latin America” at the time of our
recommendation, you’d have $17,733.03!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for
success, including guidance on building a portfolio, regular updates from
analysts, and two new stock picks each month – one from Canada and one from the
U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX
Composite Index by 36 percentage points since 2013*.



See the 15 Stocks



*Returns as of 12/26/24

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member
of The Motley Fool's board of directors. Adam Spatacco has positions in Amazon,
Eli Lilly, and Novo Nordisk. The Motley Fool has positions in and recommends
Amazon. The Motley Fool recommends Novo Nordisk. The Motley Fool has a
disclosure policy.


5 STOCKS UNDER $50 [FREE REPORT] 

We hear it over and over from investors, “I wish I had bought Amazon or Netflix
when they were first recommended by the Motley Fool. I’d be sitting on a gold
mine!” And it’s true. 

And while Amazon and Netflix have had a good run, we think these 5 other stocks
are screaming buys. And you can buy them now for less than $50 a share! 

You can grab a copy of “5 Growth Stocks Under $50” for FREE for a limited time
only.

Get Your Free Report

Related Articles

35% of Warren Buffett's $296 Billion Portfolio Is Invested in 3 Artificial
Intelligence (AI) Stocks
1 Unstoppable Stock That Could Join Nvidia, Apple, and Microsoft in the $3
Trillion Club in 2025
Artificial Intelligence (AI) Stocks Roared Higher This Year. Is It Too Late to
Invest in This High-Growth Industry?
1 Phenomenal Reason Amazon Will Have a Successful 2025
Meet the Supercharged Artificial Intelligence (AI) Growth Stock That Could Join
Apple, Nvidia, and Microsoft in the $3 Trillion Club by 2027
922%
Start Your Mornings Smarter!
Wake up to the latest market news, company insights, and a bit of Foolish
fun—all wrapped up in one quick, easy-to-read email every market day.
Enter Email Address:
By submitting your email address, you consent to us keeping you informed about
updates to our website and about other products and services that we think might
interest you. Please read our Privacy Statement and Terms & Conditions



PREMIUM INVESTING SERVICES

Invest better with The Motley Fool. Get stock recommendations, portfolio
guidance, and more from The Motley Fool's premium services.

View Premium Services

Making the world smarter, happier, and richer.

 * Facebook Facebook
 * Twitter Twitter
 * Linked In LinkedIn
 * Pinterest Pinterest
 * YouTube YouTube
 * Instagram Instagram
 * Tiktok TikTok

© 1995 - 2024 The Motley Fool. All rights reserved.

Market data powered by Xignite and Polygon.io.

About The Motley Fool

 * About Us
 * Careers
 * Research
 * Newsroom
 * Contact
 * Advertise

Our Services

 * Stock Advisor
 * Epic
 * Epic Plus
 * Fool Portfolios
 * Fool One
 * Motley Fool Money

Around the Globe

 * Fool UK
 * Fool Australia
 * Fool Canada

Free Tools

 * CAPS Stock Ratings
 * Discussion Boards
 * Calculators
 * Financial Dictionary

Affiliates & Friends

 * Motley Fool Asset Management
 * Motley Fool Wealth Management
 * Motley Fool Ventures
 * Motley Fool Foundation
 * Become an Affiliate Partner

 * Terms of Use
 * Privacy Policy
 * Disclosure Policy
 * Accessibility Policy
 * Copyright, Trademark and Patent Information
 * Terms and Conditions
 * Do Not Sell My Personal Information

Current


This website uses cookies to deliver our services and to analyze traffic. We
also share information about your use of our site with advertising and other
partners. Privacy Policy
Got it
Cookie Settings